Time to antibiotics and outcomes in cancer patients with febrile neutropenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Time to antibiotics and outcomes in cancer patients with febrile neutropenia ; volume:14 ; number:1 ; day:10 ; month:4 ; year:2014 ; pages:1-7 ; date:12.2014
BMC health services research ; 14, Heft 1 (10.4.2014), 1-7, 12.2014
- Urheber
-
Perron, Thomas
- Beteiligte Personen und Organisationen
-
Emara, Mohamed
Ahmed, Shahid
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-14-162
- URN
-
urn:nbn:de:1111-20160722776
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Perron, Thomas
- Emara, Mohamed
- Ahmed, Shahid
- SpringerLink (Online service)
Ähnliche Objekte (12)
Febrile neutropenia : with 32 tables
Oral Antibiotic Therapy for Low Risk Febrile Neutropenia: Time to Dare
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Febrile neutropenia in French emergency departments: results of a prospective multicentre survey
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Febrile neutropenia : with 32 tables
Oral Antibiotic Therapy for Low Risk Febrile Neutropenia: Time to Dare
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Febrile neutropenia in French emergency departments: results of a prospective multicentre survey
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Febrile neutropenia : with 32 tables
Oral Antibiotic Therapy for Low Risk Febrile Neutropenia: Time to Dare
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Antimicrobial stewardship in high-risk febrile neutropenia patients
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
Febrile neutropenia in French emergency departments: results of a prospective multicentre survey